National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Co-enzyme Q10 (CoQun®) HTA ID: 19045

Co-enzyme Q10 (CoQun®)  eye drops are indicated as a complementary add-on treatment to antihypertensive glaucoma therapy.

NCPE Assessment Process Complete
Rapid review commissioned 16th October 2019
Rapid review completed 13th January 2020
Rapid Review outcome A full HTA is not recommended. The NCPE recommends that CoQ10 eye drops not be considered for reimbursement*.

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.